Researchers determined a short duration of anticoagulation therapy could be beneficial in comparison to a longer course for primary treatment VTE.

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

You may like Apple Maps is my go-to choice for directions — here's how Apple Intelligence could make it even better I stopped using Apple Maps in my car after this major Google Maps update ...

Learn which antivirus and online protection suite is right for you in this Microsoft Defender vs. McAfee comparison. We discuss features, pricing and more.

CT and MRI scans produce detailed images of the body. Learn the details and differences between CT scans and MRIs, and benefits and risks of each.

Forbes Advisor analyzed Wix and Shopify, looking at important features such as cost, e-commerce capabilities, customer support, ease of use and scalability.